IPO Review - Global Health Ltd. Vs Bikaji Foods International Ltd. | CA Rachana Ranade
Published: 2022-11-04
Status:
Available
|
Analyzed
Published: 2022-11-04
Status:
Available
|
Analyzed
Predictions from this Video
Incorrect: 0
Prediction
Topic
Status
The Indian savory snacks industry, valued at 751 billion rupees in 2022, is projected to grow at a CAGR of 13%.
"The very first one Indian Savory snacks now this entire industry is valued at 751 billion rupees in 2022 and it is expected to grow at a CAGR of 13%,"
Pending
The Indian sweets industry, valued at 535 billion rupees, is largely unorganized (90%). However, the importance of the organized sector is expected to increase post-COVID-19.
"If I go on to the Sweets industry it is it is valued at 535 billion rupees of market value but out of which 90 percent belongs to the unorganized sector but I believe that after covid-19 pandemic the importance of organized sector in this space is also increasing slowly and steadily"
Pending
The Indian papad market is valued at 78 billion rupees, with the organized segment at 26 billion rupees, and is expected to grow at a CAGR of 10% by 2026.
"Indian proper Market is valued at 78 billion rupees out of which organized segment is valued at 26 billion rupees is estimated to grow at a CAGR of 10 percent by 2026."
Pending
Bikaji Foods International Limited's revenue grew at a CAGR of approximately 22% from FY 2020 to FY 2022.
"the revenue of the company grew at a CAGR of almost 22 percent from Financial year 2020 to 2022"
Pending
Global Health Limited's revenue grew at a CAGR of approximately 20% from FY 2020 to FY 2022.
"the revenue or the top line of the company grew at a CAGR of almost 20 percent from financial year 2020 to financial year 2022"
Pending
Global Health Limited's Profit After Tax (PAT) grew by 132% from FY 2020 to FY 2022, attributed to either expense control or strong pricing power.
"but PAT or the bottom line grew at 132 percentage, now what could be the reason for this extraordinary growth in profit? There could be two possibilities, possibility number one they are able to control their expenses or possibility number two like I said in the beginning because they have a good pricing power"
Pending
India has a low hospital bed density of 15 beds per 10,000 people compared to other major countries, indicating significant room for growth in the healthcare sector.
"here you can see that overall if I'm talking about bed density across countries this is about per 10,000 people how many hospital beds we have India only at 15 and when you can see all other major countries like USA or UK or even China, Russia they have a lot more than as compared to us so again same thing lot of headroom left for us to grow."
Pending
India has fewer physicians (7 per 10,000 population) and nurses (18 per 10,000 population) compared to countries like the US (26 physicians, 157 nurses per 10,000 population).
"If I am talking about Physicians per 10,000 population or be it nurses for 10,000 population again India is just at 7 and 18 as compared to someone like Us at 26 and 157."
Pending
India's healthcare expenditure is only 3% of its GDP, significantly lower than the global average of 9.8% and the US's 16.8%.
"India is only spending three percent as a percentage of GDP on the health care expenditure and if you are talking about someone again like USA, USA is at 16.8 percent other forget USA what is the global average global average is also at 9.8 percent and India is only at three percent"
Pending
The prevalence of non-communicable diseases (NCDs) in India is rapidly increasing, rising from 30% of the disease profile in 1990 to 55% in 2016, and accounting for 62% of deaths in 2016. This trend is expected to benefit hospitals like Global Health.
"the NCDs or the non-communicable diseases, the percentage of such type of diseases is increasing at a rapid rate the total contribution of NCDs to the disease profile Rose from 30 percent in 1990 to 55 percent in 2016. ... 62 percent of the deaths were because of NCDs or the non-communicable diseases,"
Pending
Global Health Limited appears to be fairly valued compared to its peers across various metrics like PE (43.24 vs 51.93 average), Price to NAV (5.26 vs 7.46 average), Market Cap/Revenue (4.09 vs 5.50 average), and EV/EBITDA (20.11 vs 25.54 average).
"average PE comes out to 51.93 but Global Health P comes to 43.24, if I were to directly jump to the Price to NAV ratio, you can see that the average of all these peers is 7.46 but for Global Health it is at 5.26 even if I'm talking about Market Capital Revenue it's at 5.50 the average of pairs and for Global Health it's coming to 4.09 and finally EV/EBITDA is at 25.54 versus EV by EBITDA for Global at 20.11"
Pending
Analysts predict a strong outlook for hospitals, expecting momentum to continue in FY23, driven by pent-up demand for elective surgeries and post-COVID complications.
"analysts believe that the hospitals are structurally well placed and the momentum is expected to continue in the QY FY 23 as well, in fact they have also mentioned that overall one important lever for all these things can be about because of the incremental elective surgeries due to pent-up demand post Covid and post Covid complications"
Pending
Global Health Limited faces a significant challenge with a doctor attrition rate of 31.43% in FY 2022, meaning roughly one in three doctors leaves the hospital annually.
"the attrition rates for doctors is almost 31.43 percent in financial year 2022, for nurses it is 50.74 in financial year 2022 and others if I am talking about other health care professionals it's 18.62 percent in 2022, so if I'm talking about doctors see doctors are going to be the main Personnel for any hospital and if the attrition rate is almost 30 percent it's as good as one out of three doctors is leaving your hospital in one year"
Pending
Global Health Limited's nurse attrition rate was 50.74% in FY 2022.
"for nurses it is 50.74 in financial year 2022"
Pending